VERU - Veru Inc logo

VERU

Veru Inc

Veru Inc. develops biopharmaceuticals targeting metabolic diseases and oncology. Its key products include enobosarm for muscle preservation in elderly patients and sabizabulin for viral lung infections. It also offers the FC2 female condom for dual protection.

โš•๏ธ Healthcare NASDAQ Listed 1990 $ USD
$1,000 invested 30 years ago โ†’$65today

Score Overview

1 Year
Scoreโ€”
Net Growth40.12%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.3
Net Growth-284.04%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-99.50%
Rev Trend40%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-39x
Net Trend50%
Net Income Consistency
Rev Growth-98.63%
Rev Trend60%
Revenue Consistency
20 Years
Score2.3
Net Growth-48x
Net Trend55%
Net Income Consistency
Rev Growth-97.95%
Rev Trend55%
Revenue Consistency
30 Years
Score
Net Growth-57.14%
Net Trend63%
Net Income Consistency
Rev Growth-85.30%
Rev Trend63%
Revenue Consistency
All Time
Score
Net Growth-45x
Net Trend58%
Net Income Consistency
Rev Growth-97.16%
Rev Trend61%
Revenue Consistency

See the full market ranking โ†’

Veru Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 42M to $ 0.00 and net income went from -$ 18M to -$ 22M. Revenue increased in 2 of those 5 years; net income in 3.

Between 1995 and 2025, revenue declined from $ 2M to $ 0.00 and net income went from -$ 8M to -$ 22M. Revenue increased in 19 of those 30 years; net income in 19.

Veru Inc currently holds a 20-year HDB Score of 2.3 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 2.74โ€”
1 Year2025-08-12
$ 3.17-13.56%
5 Years2021-08-12
$ 74.40-96.32%
10 Years2016-08-12
$ 13.20-79.24%
20 Years2006-08-11
$ 13.57-79.81%
30 Years1996-08-12
$ 41.85-93.45%
All Time1990-07-19
$ 60.51-95.47%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 303.45K-$ 13M$ 23M
2025$ 0.00-$ 22M$ 18M
2024$ 16M-$ 37M$ 24M
2023$ 16M-$ 93M$ 9M
2022$ 39M-$ 83M$ 80M
2021$ 61M$ 7M$ 122M
2020$ 42M-$ 18M$ 13M
2019$ 31M-$ 12M$ 6M
2018$ 15M-$ 23M$ 3M
2017$ 13M-$ 6M$ 3M
2016$ 22M$ 344.73K$ 2M
2015$ 32M$ 4M$ 4M
2014$ 24M$ 2M$ 5M
2013$ 31M$ 14M$ 8M
2012$ 35M$ 15M$ 5M
2011$ 18M$ 5M$ 4M
2010$ 22M$ 6M$ 2M
2009$ 27M$ 6M$ 2M
2008$ 25M$ 4M$ 1M
2007$ 19M$ 1M$ 799.42K
2006$ 14M$ 282.03K$ 1M
2005$ 11M-$ 1M$ 1M
2004$ 8M-$ 2M$ 755.48K
2003$ 9M-$ 2M$ 632.29K
2002$ 8M-$ 3M$ 558.64K
2001$ 6M-$ 1M$ 469.41K
2000$ 5M-$ 3M$ 457.12K
1999$ 4M-$ 3M$ 570.71K
1998$ 5M-$ 3M$ 1M
1997$ 2M-$ 5M$ 1M
1996$ 2M-$ 8M$ 1M
1995$ 2M-$ 8M$ 1M
1994$ 16M-$ 3M$ 3M
1993$ 12M-$ 3M
1992$ 11M-$ 4M$ 100K
1991$ 13M-$ 1M$ 1M
IPO1990$ 10M$ 300K$ 4M

Explore beyond VERU

You're looking at Veru Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies